FDA Inspection 980107 — Aurolife Pharma, LLC
The FDA completed an inspection of Aurolife Pharma, LLC on July 28, 2016 in Dayton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 28, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dayton, NJ (United States)